Dalata shareholders to vote on €1.4 billion acquisition by Pandox-led consortium

Published 12/08/2025, 15:28
Dalata shareholders to vote on €1.4 billion acquisition by Pandox-led consortium

DUBLIN - Dalata Hotel Group has published a scheme document detailing the proposed €1.4 billion acquisition by a consortium led by Pandox AB and Eiendomsspar AS, according to a press release statement issued Tuesday.

The acquisition, which was initially announced on July 15, will be implemented through a newly-incorporated company, Pandox Ireland Tuck Limited. Under the terms of the deal, Dalata shareholders will receive €6.45 in cash for each share held.

Shareholders will vote on the proposed acquisition at meetings scheduled for September 11 at the Clayton Hotel Dublin Airport. The transaction requires approval at two separate scheme meetings, followed by an extraordinary general meeting.

The first scheme meeting at 12:00 p.m. will be for consortium shareholders, while the second meeting at 12:05 p.m. will be for independent Dalata shareholders. The extraordinary general meeting will follow at 12:15 p.m.

The companies have established an expected timetable for the acquisition, with the scheme anticipated to become effective in October 2025, subject to court approval and satisfaction of conditions.

On August 11, the parties entered into a deed of amendment regarding the transaction agreement and irrevocable undertakings to conform voting obligations to applicable antitrust law requirements.

Once effective, the scheme will be binding on all scheme shareholders regardless of whether they attended or voted at the meetings.

The acquisition values Dalata’s entire issued and to-be-issued share capital at approximately €1.4 billion on a fully diluted basis. The transaction is expected to be completed before the end of November 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.